Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-19-106612
Filing Date
2019-04-15
Accepted
2019-04-15 16:38:46
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d715130d424b5.htm 424B5 511640
2 GRAPHIC g715130g05r47.jpg GRAPHIC 42165
3 GRAPHIC g715130g30u90.jpg GRAPHIC 122795
  Complete submission text file 0001193125-19-106612.txt   740128
Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-229377 | Film No.: 19748987
SIC: 2836 Biological Products, (No Diagnostic Substances)